{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:53:39Z","timestamp":1790538819978,"version":"4.1.0"},"reference-count":149,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.crohns.2010.05.006","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T08:24:13Z","timestamp":1277799853000},"page":"511-522","source":"Crossref","is-referenced-by-count":90,"title":["Hepatosplenic T-cell lymphoma and inflammatory bowel disease"],"prefix":"10.1093","volume":"4","author":[{"given":"Anne","family":"Thai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Prindiville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2010.05.006_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJM198103123041106","article-title":"Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis","volume":"304","author":"Kadin","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/cncr.2820690510","article-title":"Lymphoma in inflammatory bowel disease","volume":"69","author":"Greenstein","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00054725-200105000-00005","article-title":"The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients","volume":"7","author":"Arseneau","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.05.006_bib5","unstructured":"Bethesda MD Surveillance Epidemiology and End Results (SEER) Database. National Cancer Institute <http:\/\/seer.cancer.gov 1975\u20132004\/>."},{"key":"10.1016\/j.crohns.2010.05.006_bib6","first-page":"617","article-title":"Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma\/delta T-cell lymphomas","volume":"137","author":"Gaulard","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.05.006_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.crohns.2010.05.006_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: A report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib10","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.05.006_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.05.006_bib12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V87.4.1474.bloodjournal8741474","article-title":"Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes","volume":"87","author":"Macon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.05.006_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.05.006_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190802087488","article-title":"Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha","volume":"49","author":"Humphreys","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2559.2000.00804.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules","volume":"36","author":"Ohshima","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.crohns.2010.05.006_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00000478-200003000-00016","article-title":"Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia","volume":"24","author":"Lai","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2169\/internalmedicine.43.120","article-title":"Gamma\/delta T cell lymphoma","volume":"43","author":"Taguchi","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma\u2013delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00043426-200202000-00020","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl","volume":"24","author":"Rossbach","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1440-1827.2006.02027.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections","volume":"56","author":"Hassan","year":"2006","journal-title":"Pathol Int"},{"key":"10.1016\/j.crohns.2010.05.006_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","article-title":"Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine","volume":"44","author":"Navarro","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.mph.0000243649.43863.8f","article-title":"The first infant case with hepatosplenic gammadelta T-cell lymphoma after acute disseminated encephalomyelitis (ADEM)-like exacerbation","volume":"28","author":"Koga","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0609.2004.00300.x","article-title":"Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature","volume":"73","author":"Niitsu","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00428-006-0267-5","article-title":"Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration","volume":"449","author":"Tamaska","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.crohns.2010.05.006_bib26","first-page":"49:763","article-title":"Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children","author":"Lo Nigro","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10428190500293321","article-title":"Gamma\u2013delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone","volume":"47","author":"Moleti","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib30","first-page":"1134","article-title":"Hepatosplenic gammadelta T cell lymphoma and its relationship with Epstein-Barr virus infection","volume":"14","author":"Gao","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.crohns.2010.05.006_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.10466","article-title":"Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation","volume":"75","author":"Gassas","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib32","article-title":"Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen","author":"Tey","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000091427","article-title":"Progressive multifocal leukoencephalopathy in a patient with hepatosplenic T cell lymphoma","volume":"55","author":"Gonzalez de la Aleja","year":"2006","journal-title":"Eur Neurol"},{"key":"10.1016\/j.crohns.2010.05.006_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3748\/wjg.v9.i6.1381","article-title":"Hepato-splenic lymphoma: a rare entity mimicking acute hepatitis: a case report","volume":"9","author":"Perfetto","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.05.006_bib35","first-page":"215","article-title":"Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection","volume":"44","author":"Ozaki","year":"1998","journal-title":"J Med Invest"},{"key":"10.1016\/j.crohns.2010.05.006_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejim.2006.09.027","article-title":"Hepatosplenic gammadelta T-cell lymphoma: a case report","volume":"18","author":"Meulenbeld","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib37","first-page":"387","article-title":"Clinicopathologic study of hepatosplenic T-cell lymphoma","volume":"40","author":"Zhang","year":"2008","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.crohns.2010.05.006_bib38","first-page":"217","article-title":"Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases","volume":"28","author":"Li","year":"2007","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.crohns.2010.05.006_bib39","first-page":"593","article-title":"Spontaneous splenic rupture associated with hepatosplenic gammadelta T-cell lymphoma","volume":"104","author":"Chen","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.crohns.2010.05.006_bib40","first-page":"88","article-title":"Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study","volume":"24","author":"Geng","year":"2004","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"10.1016\/j.crohns.2010.05.006_bib41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00277-008-0523-7","article-title":"Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation","volume":"87","author":"Otrock","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-008-9561-1","article-title":"Pituitary gland involvement by a gamma delta hepatosplenic lymphoma, a mimicker of pituitary adenoma: report of a rare case","volume":"88","author":"Jain","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.revmed.2007.04.007","article-title":"Dermatomyositis associated with hepatosplenic gamma delta T-cell lymphoma","volume":"28","author":"Chandesris","year":"2007","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.crohns.2010.05.006_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/10428190601126941","article-title":"Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma","volume":"48","author":"Konuma","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.bmt.1705615","article-title":"Hepatosplenic alphabeta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation","volume":"39","author":"Machino","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.crohns.2010.05.006_bib46","first-page":"76","article-title":"Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report","volume":"128","author":"Kalac","year":"2006","journal-title":"Lijec Vjesn"},{"key":"10.1016\/j.crohns.2010.05.006_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cancergencyto.2005.12.003","article-title":"Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma","volume":"167","author":"Shetty","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.crohns.2010.05.006_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5507\/bp.2005.040","article-title":"T-cell gamma\/delta hepatosplenic lymphoma \u2014 prolonged remission induced by aggressive first line treatment","volume":"149","author":"Prochazka","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.crohns.2010.05.006_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1532\/IJH97.04149","article-title":"Hepatosplenic alphabeta T-cell lymphoma with myelodysplastic syndrome","volume":"82","author":"Takaku","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib50","first-page":"505","article-title":"A case of hepatosplenic gammadelta T cell lymphoma","volume":"13","author":"Wang","year":"2005","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.crohns.2010.05.006_bib51","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.3748\/wjg.v11.i24.3729","article-title":"Hepatosplenic gammadelta T-cell lymphoma","volume":"11","author":"Wei","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.05.006_bib52","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bmt.1704897","article-title":"Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma","volume":"35","author":"Mansour","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.crohns.2010.05.006_bib53","first-page":"ECR14","article-title":"Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.crohns.2010.05.006_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2141.2000.02129.x","article-title":"In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+T-cell malignancies","volume":"110","author":"Aldinucci","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428190109099342","article-title":"2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma","volume":"42","author":"Grigg","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib56","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin","volume":"117","author":"Iannitto","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib57","first-page":"341","article-title":"Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma","volume":"63","author":"Munir","year":"2004","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.crohns.2010.05.006_bib58","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/10428190310001609924","article-title":"Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha\/beta hepatosplenic T-cell non-Hodgkin's lymphoma","volume":"45","author":"Chanan-Khan","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00043426-200406000-00008","article-title":"Hemophagocytic syndrome and hepatosplenic gammadelta T-cell lymphoma with isochromosome 7q and 8 trisomy","volume":"26","author":"Chin","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib60","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1827.2004.01752.x","article-title":"Clinicopathological features of eight Korean cases of primary hepatic lymphoma","volume":"54","author":"Eom","year":"2004","journal-title":"Pathol Int"},{"key":"10.1016\/j.crohns.2010.05.006_bib61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1055\/s-2003-44298","article-title":"Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma","volume":"41","author":"Petersen-Benz","year":"2003","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.crohns.2010.05.006_bib62","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jcp.56.8.631","article-title":"Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules","volume":"56","author":"Sadahira","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib63","first-page":"519","article-title":"Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine","volume":"32","author":"Gopcsa","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"10.1016\/j.crohns.2010.05.006_bib64","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2003.05.176","article-title":"Hematologic malignancies with extramedullary spread of disease. Case 2. Hepatosplenic T-cell lymphoma","volume":"21","author":"Shahab","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib65","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.5858\/2003-127-e119-HTLARO","article-title":"Hepatosplenic alpha beta T-cell lymphoma: a report of an S100-positive case","volume":"127","author":"Dong","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1365-2141.2002.03934.x","article-title":"Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes","volume":"119","author":"Costes","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/hupa.2002.31301","article-title":"Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation","volume":"33","author":"Steurer","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib68","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.5555","article-title":"Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome)","volume":"69","author":"Motta","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib70","first-page":"E25","article-title":"Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma","volume":"86","author":"Ooi","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.crohns.2010.05.006_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature","volume":"116","author":"Khan","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00000478-200107000-00004","article-title":"Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution","volume":"25","author":"Allory","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib73","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/00000478-200107000-00020","article-title":"Hepatosplenic T-cell lymphoma of alphabeta lineage","volume":"25","author":"Kumar","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.crohns.2010.05.006_bib75","first-page":"528","article-title":"Primary hepatosplenic (gamma delta) T-cell lymphoma: clinico-pathologic analysis of 3 cases","volume":"44","author":"Plank","year":"1998","journal-title":"Vnitr L\u00e9k"},{"key":"10.1016\/j.crohns.2010.05.006_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5","article-title":"Hepatosplenic gamma\u2013delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients","volume":"113","author":"Wu","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib77","first-page":"256","article-title":"Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient","volume":"85","author":"Roncella","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.crohns.2010.05.006_bib78","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s100249900152","article-title":"Consistency of isochromosome 7q and trisomy 8 in hepatosplenic gammadelta T-cell lymphoma: detection by fluorescence In situ hybridization of a splenic touch-preparation from a pediatric patient","volume":"2","author":"Coventry","year":"1999","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib79","first-page":"186","article-title":"Gamma delta T-cell lymphoma: a clinicopathologic study of 6 cases including extrahepatosplenic type","volume":"69","author":"Yamaguchi","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib80","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<313::AID-AJH14>3.0.CO;2-G","article-title":"Case of hepatosplenic gammadelta T-cell lymphoma presenting with severe hypersplenism","volume":"60","author":"Dincol","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L","article-title":"Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome","volume":"60","author":"Nosari","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib82","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crohns.2010.05.006_bib83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4","article-title":"Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas","volume":"183","author":"Boulland","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<983::AID-CNCR26>3.0.CO;2-W","article-title":"T gamma\/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report","volume":"82","author":"Kraus","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0925-5710(97)00594-X","article-title":"Hepatosplenic T-cell lymphoma: prolymphocytic transformation 18months after splenectomy","volume":"66","author":"Sohn","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib86","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.crohns.2010.05.006_bib87","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00000478-199707000-00006","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q","volume":"21","author":"Francois","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0740-2570(03)00013-3","article-title":"Splenic involvement by peripheral T-cell and NK-cell neoplasms","volume":"20","author":"Chan","year":"2003","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib89","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0046-8177(97)90176-3","article-title":"Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation","volume":"28","author":"Salhany","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<278::AID-AJH16>3.0.CO;2-8","article-title":"Hepatosplenic T-cell lymphoma: sinusoidal localization of malignant T-cells\u2014a case report","volume":"53","author":"Kakkar","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib91","first-page":"1453","article-title":"Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma\/delta lymphoma","volume":"10","author":"Jonveaux","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.crohns.2010.05.006_bib92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10428199609054788","article-title":"Clinical and hematological characteristics of hepatosplenic T gamma\/delta lymphoma with isochromosome for long arm of chromosome 7","volume":"22","author":"Yao","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib93","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/1097-0142(19951015)76:8<1336::AID-CNCR2820760807>3.0.CO;2-I","article-title":"Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features, and outcome","volume":"76","author":"Lei","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib94","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.1995.tb05221.x","article-title":"Hepatosplenic gamma\u2013delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up","volume":"90","author":"Garcia-Sanchez","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib95","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00000478-199506000-00013","article-title":"Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type","volume":"19","author":"Wong","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib96","first-page":"355","article-title":"Peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient","volume":"8","author":"Labouyrie","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib98","first-page":"629","article-title":"Occult hepatosplenic T-gamma delta lymphoma. Value of genotypic analysis in the differential diagnosis","volume":"426","author":"Dommann-Scherrer","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1016\/j.crohns.2010.05.006_bib99","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ajcp\/102.3.310","article-title":"Gamma\/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen","volume":"102","author":"Ross","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0046-8177(94)90244-5","article-title":"In situ localization of Epstein-Barr virus encoded RNA in non-nasal\/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas","volume":"25","author":"Tsang","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0046-8177(94)90179-1","article-title":"Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation","volume":"25","author":"Mastovich","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib102","first-page":"269","article-title":"Gamma\/delta T-cell lymphoma with hepatosplenomegaly: report of a case","volume":"57","author":"Ohno","year":"1993","journal-title":"Int J Hematol"},{"key":"10.1016\/j.crohns.2010.05.006_bib103","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","article-title":"Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.crohns.2010.05.006_bib104","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/1097-0142(19930415)71:8<2639::AID-CNCR2820710832>3.0.CO;2-Q","article-title":"Malignant lymphoma imitating hepatitis","volume":"71","author":"Harris","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.crohns.2010.05.006_bib105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.crohns.2010.05.006_bib106","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.142.9.3045","article-title":"Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans","volume":"142","author":"Bucy","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.crohns.2010.05.006_bib107","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.171.5.1597","article-title":"Evidence for extrathymic changes in the T cell receptor gamma\/delta repertoire","volume":"171","author":"Parker","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib108","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.11.056","article-title":"Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice","volume":"134","author":"Nanno","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib109","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.05.006_bib110","first-page":"1723","article-title":"Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.05.006_bib111","unstructured":"Horsham, PA. Remicade (infliximab): hepatosplenic T-cell Lymphoma; March 2010 Nov\u2013Dec."},{"key":"10.1016\/j.crohns.2010.05.006_bib112","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.05.006_bib113","doi-asserted-by":"crossref","first-page":"A116","DOI":"10.1016\/S0016-5085(08)60543-0","article-title":"Excessive Risk of Lymphoproliferative Disorders (LPD) in Inflammatory Bowel Disease (IBD): interim results of the cesame cohort. (Abstract)","volume":"134","author":"Beaugerie","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib114","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cgh.2006.03.018","article-title":"Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease","volume":"4","author":"Disanti","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.05.006_bib115","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.crohns.2010.05.006_bib116","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2010.05.006_bib117","first-page":"S30","article-title":"Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD","volume":"3","author":"Seidman","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.crohns.2010.05.006_bib118","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib119","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2010.05.006_bib120","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.05.006_bib121","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18, 572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib122","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.2005.075937","article-title":"Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study","volume":"55","author":"Biancone","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.05.006_bib123","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.crohns.2010.05.006_bib124","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.crohns.2010.05.006_bib125","first-page":"e259","article-title":"Hepatosplenic T-cell lymphoma in a 15 -year-old boy with ulcerative colitis treated with azathioprine for 9years","volume":"44","author":"Keller","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.05.006_bib126","first-page":"A1020","article-title":"Intravenous cyclosporine for refractory attacks of Crohn's disease (CD): long-term follow-up of patients [abstract}","volume":"114","author":"Lemann","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib127","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(00)70353-2","article-title":"Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma","volume":"118","author":"Lewis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib128","doi-asserted-by":"crossref","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med;362:1383\u201395.","DOI":"10.1056\/NEJMoa0904492"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2010.05.006_bib129","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s10620-005-2804-5","article-title":"Cellular and molecular mechanisms of the epithelial repair in IBD","volume":"50","author":"Okamoto","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2010.05.006_bib130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Froslie","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib131","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/gut.2005.088732","article-title":"Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?","volume":"56","author":"Rutgeerts","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.05.006_bib132","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.05.006_bib133","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1053\/j.gastro.2008.04.029","article-title":"Combination therapy with infliximab and immunomodulators: is the glass half empty?","volume":"134","author":"Deshpande","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl 5","key":"10.1016\/j.crohns.2010.05.006_bib134","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.05.006_bib135","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10428190701345433","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy","volume":"48","author":"Zeidan","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2010.05.006_bib136","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0b013e31818cf555","article-title":"Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?","volume":"48","author":"Cucchiara","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.05.006_bib137","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","article-title":"Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial","volume":"134","author":"Van Assche","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.05.006_bib138","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease","volume":"348","author":"Baert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2010.05.006_bib139","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/ard.2008.092833","article-title":"Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis","volume":"68","author":"Radstake","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.crohns.2010.05.006_bib140","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","article-title":"Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease","volume":"56","author":"Vermeire","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.05.006_bib141","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial","volume":"371","author":"D'Haens","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2010.05.006_bib142","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.20712","volume":"52","author":"Quinn","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib143","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib144","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib145","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/art.23055","article-title":"Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone","volume":"56","author":"Durez","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib146","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3899\/jrheum.081018","article-title":"Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis","volume":"36","author":"Emery","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.crohns.2010.05.006_bib147","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib148","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.24638","volume":"60","author":"Emery","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.crohns.2010.05.006_bib149","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/art.20159","article-title":"Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate","volume":"50","author":"Maini","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S187399461000084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S187399461000084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/4\/5\/511\/7000740\/4-5-511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:49:10Z","timestamp":1685648950000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2010.05.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S187399461000084X"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2010.05.006","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}